Matthew Locke

704 total citations
15 papers, 533 citations indexed

About

Matthew Locke is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Matthew Locke has authored 15 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Matthew Locke's work include Blood properties and coagulation (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Muscle Physiology and Disorders (2 papers). Matthew Locke is often cited by papers focused on Blood properties and coagulation (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Muscle Physiology and Disorders (2 papers). Matthew Locke collaborates with scholars based in United Kingdom, Switzerland and Italy. Matthew Locke's co-authors include Derek J. Blake, Caroline L. Tinsley, Colin Longstaff, Matthew A. Benson, Adrian J. Waite, Julia I. Toth, Matthew D. Petroski, Philip Beesley, Roy V. Sillitoe and Michaela Kraus and has published in prestigious journals such as Scientific Reports, Biochemical Journal and FEBS Letters.

In The Last Decade

Matthew Locke

13 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Locke United Kingdom	10	287	125	92	88	79	15	533
Zhouteng Tao China	11	577 2.0×	77 0.6×	239 2.6×	53 0.6×	40 0.5×	15	906
B. Blanchard France	8	222 0.8×	40 0.3×	81 0.9×	200 2.3×	42 0.5×	8	547
Sylvia Torres-Odio United States	11	350 1.2×	45 0.4×	67 0.7×	144 1.6×	15 0.2×	16	575
Harry Holzmüller Germany	10	324 1.1×	79 0.6×	19 0.2×	99 1.1×	115 1.5×	11	595
Jean‐Marie Mussini France	10	278 1.0×	54 0.4×	80 0.9×	39 0.4×	30 0.4×	16	646
Marco Boccitto United States	9	328 1.1×	42 0.3×	38 0.4×	123 1.4×	74 0.9×	13	572
Kouzou Fukuyama Japan	15	263 0.9×	39 0.3×	121 1.3×	33 0.4×	24 0.3×	30	705
Donald W. Lawrence United States	11	211 0.7×	39 0.3×	24 0.3×	182 2.1×	30 0.4×	15	545
Xueyan Guo China	12	268 0.9×	34 0.3×	38 0.4×	84 1.0×	25 0.3×	29	463
E.O. Riecken Germany	15	300 1.0×	89 0.7×	38 0.4×	87 1.0×	106 1.3×	40	669

Countries citing papers authored by Matthew Locke

Since Specialization

Citations

This map shows the geographic impact of Matthew Locke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Locke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Locke more than expected).

Fields of papers citing papers by Matthew Locke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Locke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Locke. The network helps show where Matthew Locke may publish in the future.

Co-authorship network of co-authors of Matthew Locke

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Locke. A scholar is included among the top collaborators of Matthew Locke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Locke. Matthew Locke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Locke, Matthew, et al.. (2025). Next-generation FVIIIa-mimetic bispecific antibody NXT007: evaluation in preclinical models of hemostasis and thrombosis. Blood Advances. 10(4). 1058–1067.

Locke, Matthew, Colin Longstaff, & Peter Rigsby. (2021). An international collaborative study to establish the WHO 3rd International Standard for Thrombin: Communication from the ISTH SSC subcommittee on factor XIII and fibrinogen. Journal of Thrombosis and Haemostasis. 19(3). 852–858.

Locke, Matthew & Colin Longstaff. (2020). Extracellular Histones Inhibit Fibrinolysis through Noncovalent and Covalent Interactions with Fibrin. Thrombosis and Haemostasis. 121(4). 464–476. 43 indexed citations

Locke, Matthew, Peter Rigsby, & Colin Longstaff. (2020). An international collaborative study to establish the WHO 4th International Standard for Streptokinase: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 18(6). 1501–1505. 2 indexed citations

Locke, Matthew & Colin Longstaff. (2020). How treatment delay may lead to loss of effectiveness of tranexamic acid. ANZ Journal of Surgery. 90(4). 416–418. 2 indexed citations

Locke, Matthew, et al.. (2020). Fibrinogen protects neutrophils from the cytotoxic effects of histones and delays neutrophil extracellular trap formation induced by ionomycin. Scientific Reports. 10(1). 11694–11694. 25 indexed citations

Thelwell, Craig, et al.. (2018). An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140): communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 16(5). 1003–1006. 4 indexed citations

Longstaff, Colin & Matthew Locke. (2018). Increased urokinase and consumption of α2‐antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay. Journal of Thrombosis and Haemostasis. 17(1). 195–205. 23 indexed citations

Locke, Matthew, Essam Ghazaly, Marta O. Freitas, et al.. (2016). Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1. Cell Reports. 16(6). 1604–1613. 46 indexed citations

10.

Locke, Matthew, Julia I. Toth, & Matthew D. Petroski. (2014). Lys11- and Lys48-linked ubiquitin chains interact with p97 during endoplasmic-reticulum-associated degradation. Biochemical Journal. 459(1). 205–216. 50 indexed citations

11.

Locke, Matthew, Caroline L. Tinsley, Matthew A. Benson, & Derek J. Blake. (2009). TRIM32 is an E3 ubiquitin ligase for dysbindin. Human Molecular Genetics. 18(13). 2344–2358. 111 indexed citations

12.

Borg, Kristian, Rolf Stucka, Matthew Locke, et al.. (2009). Intragenic deletion ofTRIM32in compound heterozygotes with sarcotubular myopathy/LGMD2H. Human Mutation. 30(9). E831–E844. 29 indexed citations

13.

Waite, Adrian J., Caroline L. Tinsley, Matthew Locke, & Derek J. Blake. (2009). The neurobiology of the dystrophin-associated glycoprotein complex. Annals of Medicine. 41(5). 344–359. 97 indexed citations

14.

Esapa, Christopher T., Adrian J. Waite, Matthew Locke, et al.. (2007). SGCE missense mutations that cause myoclonus-dystonia syndrome impair ε-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Human Molecular Genetics. 16(3). 327–342. 87 indexed citations

15.

Coffey, Marcus J., Barbara Coles, Matthew Locke, et al.. (2004). Interactions of 12‐lipoxygenase with phospholipase A₂isoforms following platelet activation through the glycoprotein VI collagen receptor. FEBS Letters. 576(1-2). 165–168. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact